Wedbush Equities Analysts Lower Earnings Estimates for ELEV
Elevation Oncology, Inc. (NASDAQ:ELEV – Free Report) – Analysts at Wedbush cut their Q2 2025 earnings per share (EPS) estimates for Elevation Oncology in a note issued to investors on Monday, June 9th. Wedbush analyst R. Driscoll now expects that the company will post earnings per share of ($0.32) for the quarter, down from their […]
Elevation Oncology, Inc. (NASDAQ:ELEV – Free Report) – Analysts at Wedbush cut their Q2 2025 earnings per share (EPS) estimates for Elevation Oncology in a note issued to investors on Monday, June 9th. Wedbush analyst R. Driscoll now expects that the company will post earnings per share of ($0.32) for the quarter, down from their […]
